Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIMPLANTATIONGeneric

VITRASERT

GANCICLOVIR

Standard Dose
4.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview VITRASERT is listed in Drugs@FDA under application 020569 (NDA).

Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength IMPLANT;IMPLANTATION - 4.5MG Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2000-04-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview VITRASERT is listed in Drugs@FDA under application 020569 (NDA). Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength IMPLANT;IMPLANTATION - 4.5MG Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2000-04-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.